Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial.
- DOI
- 10.1016/j.ejca.2022.07.028
- Published
- 2022 Oct
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2022.07.028,
title = {Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial.},
author = {Villacampa G and Falato C and Paré L and Hernando C and Arumí M and Saura C and Gómez G and Muñoz M and Gil-Gil M and Izarzugaza Y and Ferrer N and Najera-Zuloaga J and Montaño A and Ciruelos E and González-Santiago S and Villagrasa P and Gavilá J and Prat A and Pascual T},
year = {2022},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/j.ejca.2022.07.028},
url = {https://doi.org/10.1016/j.ejca.2022.07.028}
}RIS
TY - JOUR TI - Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial. AU - Villacampa G AU - Falato C AU - Paré L AU - Hernando C AU - Arumí M AU - Saura C AU - Gómez G AU - Muñoz M AU - Gil-Gil M AU - Izarzugaza Y AU - Ferrer N AU - Najera-Zuloaga J AU - Montaño A AU - Ciruelos E AU - González-Santiago S AU - Villagrasa P AU - Gavilá J AU - Prat A AU - Pascual T PY - 2022 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/j.ejca.2022.07.028 UR - https://doi.org/10.1016/j.ejca.2022.07.028 ER -
APA
G, V., C, F., L, P., C, H., M, A., C, S., G, G., M, M., M, G., Y, I., N, F., J, N., A, M., E, C., S, G., P, V., J, G., A, P., & T, P. (2022). Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2022.07.028
Source records
- pubmed · retrieved 2026-09-26T23:51:24.373Z